[Form 4] Monro, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Monro director Lindsay Hyde was granted 8,306 restricted shares on 08/12/2025 under the company’s Amended and Restated 2007 Stock Incentive Plan. The award was issued at a stated price of $0 and increases Hyde’s direct beneficial ownership to 30,728 shares.

The restricted shares vest one-third on each of the three anniversaries of the grant date, so the award converts to unrestricted shares over a three-year schedule if vesting conditions are met. This filing discloses a routine equity compensation grant to a director.

Positive

• Restricted stock award granted to a director under the company’s Amended and Restated 2007 Stock Incentive Plan
• Time-based vesting (one-third each anniversary) supports director retention and alignment with shareholders

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity award that aligns interests via time-based vesting; disclosure shows direct ownership increased to 30,728 shares.

The Form 4 reports a standard restricted stock award to a director under the company’s 2007 Stock Incentive Plan. The grant of 8,306 shares at a $0 price with vesting of one-third annually is consistent with time-based retention and alignment practices for non-employee directors. The filing documents the change in direct beneficial ownership to 30,728 shares and provides the vesting schedule in the disclosure. The filing does not include information on total outstanding shares or relative dilution.

Compensation Analyst

TL;DR: Compensation grant appears to be a typical restricted stock award for board service with multi-year vesting; materiality versus outstanding shares not provided.

The award is described as a Restricted Stock Award granted on 08/12/2025 under the Amended and Restated 2007 Stock Incentive Plan and vests one-third each anniversary. The stated grant size is 8,306 shares and the post-transaction direct ownership is 30,728 shares. The report is a routine disclosure of director compensation; the filing does not provide company-level metrics needed to assess percent dilution or dollar value relative to peer grants.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hyde Lindsay

(Last) (First) (Middle)

295 WOODCLIFF DRIVE

SUITE 202

(Street)

FAIRPORT NY 14450

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MONRO, INC. [ MNRO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Restricted Stock Award	08/12/2025		A		8,306(1)	A	$0	30,728	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the "Plan") and vests one-third on each of the three anniversaries of the grant date.

	Lindsay Hyde	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Monro (MNRO) director Lindsay Hyde receive?

Lindsay Hyde received a Restricted Stock Award of 8,306 shares on 08/12/2025 under the Amended and Restated 2007 Stock Incentive Plan.

How many MNRO shares does Lindsay Hyde beneficially own after the transaction?

The filing reports 30,728 shares beneficially owned by Lindsay Hyde following the reported transaction, held in a direct ownership form.

What is the vesting schedule for the restricted shares granted to Hyde?

The award vests one-third on each of the three anniversaries of the grant date.

What price was paid for the restricted shares in the MNRO Form 4?

The restricted stock award was granted at a stated price of $0.

What relationship does Lindsay Hyde have to Monro (MNRO)?

The Form 4 identifies Lindsay Hyde as a Director of Monro, Inc.